High-throughput rna-seq
US-2016122753-A1 · May 5, 2016 · US
US10465242B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10465242-B2 |
| Application number | US-201715650832-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 14, 2017 |
| Priority date | Jul 14, 2016 |
| Publication date | Nov 5, 2019 |
| Grant date | Nov 5, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems, devices, and methods for capturing single source-specific biological material from a multi-source aggregate of biological material are disclosed and discussed. A capture system is generated using reversible chain-blocking to make capture substrates having substrate-linked populations of capture molecules specific for molecules of interest. Incubating such capture substrates in the presence of only a single source of biological material facilitates the association of molecules of interest from the same source. Capture substrate-specific barcode sequences coupled to the capture molecules allow multisource aggregate processing and subsequent grouping to retain the source-specific information following downstream processing.
Opening claim text (preview).
The invention claimed is: 1. A method of making a multi-probe capture system, comprising: synthesizing a plurality of barcode sequences extending from a capture substrate, where the plurality of barcode sequences includes a specific identifier to the capture substrate; protecting a first portion of the plurality of barcode sequences with a first protecting group; and protecting a second portion of the plurality of barcode sequences with a second protecting group, where the second protecting group is stable under conditions for deprotection of the first protecting group, stable under conditions for oligonucleotide synthesis, and is capable of deprotection under conditions compatible with oligonucleotides. 2. The method of claim 1 , further comprising: deprotecting the first portion of the plurality of barcode sequences by removing the first protecting group; synthesizing a plurality of first oligonucleotide primers extending from the first portion of the plurality of barcode sequences; deprotecting the second portion of the plurality of barcode sequences by removing the second protecting group; and synthesizing a plurality of second oligonucleotide primers extending from the second portion of the plurality of barcode sequences. 3. The method of claim 2 , further comprising capping terminal ends of the plurality of first oligonucleotide primers prior to deprotecting the second portion of the plurality of barcode sequences. 4. The method of claim 2 , wherein the plurality of first oligonucleotide primers and the plurality of second oligonucleotide primers are sequenced 5′ to 3′. 5. The method of claim 2 , wherein protecting the first and second portions of the plurality of barcode sequences cormprises: reacting the plurality of barcode sequences with a mixture including: first nucleoside building blocks including the first protecting group; and second nucleoside building blocks including the second protecting group, wherein the first portion of the plurality of barcode sequences is a result of reaction with the first nucleoside building blocks and the second portion of the plurality of barcode sequences is a result of reaction with the second nucleoside building blocks. 6. The method of claim 5 , wherein the first and second nucleoside building blocks are nucleoside phosphoramidites. 7. The method of claim 6 , wherein the first protecting group is dimethoxytrityl (DMT). 8. The method of claim 6 , wherein the second protecting group is levulinyl (Lev). 9. The method of claim 5 , wherein the mixture comprises the first nucleoside building blocks and the second nucleoside building blocks in a ratio of from 1:100 to 100:1. 10. The method of claim 5 , wherein the mixture comprises the first nucleoside building blocks and the second nucleoside building blocks in a ratio of from 1:10 to 10:1. 11. The method of claim 5 , wherein the mixture comprises the first nucleoside building blocks and the second nucleoside building blocks in a ratio of from 1:4 to 4:1. 12. The method of claim 2 , wherein the plurality of first oligonucleotide primers and the plurality of second oligonucleotide primers are configured to capture a specific first mRNA and a specific second mRNA having a functional relationship with one another. 13. The method of claim 2 , wherein one of the plurality of first oligonucleotide primers and the plurality of second oligonucleotide primers is configured to capture a specific mRNA, and the other of the plurality of first oligonucleotide primers and the plurality of second oligonucleotide primers is configured to capture nonspecific mRNA.
characterised by the detection means (C12Q1/6804 takes precedence) · CPC title
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title
Particles, e.g. beads · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.